Beth C. Seidenberg SEC insider filings

Historical public-company ownership and transaction filings, with links to the original SEC records.

What the SEC filings show

Beth C. Seidenberg is named as a reporting owner in 5 source-backed SEC filings in this collection, associated with 3 public-company issuers. The most recent included filing was submitted Aug 10, 2026.

Filings may report stock transactions or holdings at a particular time. They do not establish the person's current share balance, portfolio value, total net worth, or whether a transaction was an open-market purchase or sale.

Source filings
5
Issuers represented
3
Filings with transactions
4
Filings with holdings
2

Recent SEC source documents

A selection of the latest 3 relevant source filings. Counts describe reported rows in the filing, not verified trades, economic proceeds, or personal profits. Older filings and amendments may contain different information.

FiledIssuerReported relationshipRowsOriginal SEC filing
Aug 10, 2026Latigo Biotherapeutics, Inc.Director, 10% owner14 transaction / 0 holdingForm 4 · 0001184592-26-000005
Aug 6, 2026Latigo Biotherapeutics, Inc.Director, 10% owner0 transaction / 10 holdingForm 3 · 0001184592-26-000004
Jun 3, 2015TESARO, Inc.Director2 transaction / 2 holdingForm 4 · 0001104659-15-043229

How to interpret this evidence

SEC Forms 3, 4 and 5 disclose certain ownership and transaction observations. Reporting dates, beneficial ownership, derivative instruments, indirect positions and amendments can affect interpretation. Figures here are counts of filing records, not independent valuations. Exact total net worth is not publicly known from this filing record.

Browse this reporting owner's SEC filing history

Explore people and ownership research